IGF1 and prostate carcinoma: Furthermore, since epidemiological studies have reported a positive association between circulating IGF-1 levels and various primary cancers, such as breast, colorectal, and prostate cancer (26), it is critical to examine potential carcinogenic effects of long-term IGF-1 administration in a large animal model.